Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement

DOI10.1051/mmnp:2007003zbMath1337.92111OpenAlexW2118773579MaRDI QIDQ2788513

K. Marron, Noël Dahan, Zvia Agur, Vladimir Vainstein, Yuri Kogan, Benjamin Ribba

Publication date: 19 February 2016

Published in: Mathematical Modelling of Natural Phenomena (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1051/mmnp:2007003

zbMATH Keywords

heterogeneitymathematical modelchemotherapyavascular tumourdoxorubicinhybrid cellular automataCHOPnon-Hodgkin lymphomavascular tumour

Mathematics Subject Classification ID

PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50)

Related Items

Improving Cancer Therapy by Doxorubicin and Granulocyte Colony-Stimulating Factor: Insights from a Computerized Model of Human Granulopoiesis

Cites Work

• Unnamed Item
• Unnamed Item
• A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling results
• Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugs
• A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs
• Hopf point analysis for angiogenesis models
• Growth of necrotic tumors in the presence and absence of inhibitors
• Growth of nonnecrotic tumors in the presence and absence of inhibitors
• A mathematical model of vascular tumour growth and invasion
• Improving Cancer Therapy by Doxorubicin and Granulocyte Colony-Stimulating Factor: Insights from a Computerized Model of Human Granulopoiesis